Andreas Røder
Andreas Røder
Copenhagen Prostate Cancer Center
Verified email at - Homepage
Cited by
Cited by
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ...
Nature genetics 50 (7), 928-936, 2018
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
RA Eeles, AAA Olama, S Benlloch, EJ Saunders, DA Leongamornlert, ...
Nature genetics 45 (4), 385-391, 2013
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
AA Al Olama, Z Kote-Jarai, SI Berndt, DV Conti, F Schumacher, Y Han, ...
Nature genetics 46 (10), 1103-1109, 2014
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Z Kote-Jarai, AAA Olama, GG Giles, G Severi, J Schleutker, M Weischer, ...
Nature genetics 43 (8), 785-791, 2011
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ...
Nature genetics 53 (1), 65-75, 2021
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
CC Parker, NW Clarke, AD Cook, HG Kynaston, PM Petersen, C Catton, ...
The Lancet 396 (10260), 1413-1421, 2020
Active surveillance for clinically localized prostate cancer––A systematic review
FB Thomsen, K Brasso, LH Klotz, MA Røder, KD Berg, P Iversen
Journal of surgical oncology 109 (8), 830-835, 2014
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
TM Seibert, CC Fan, Y Wang, V Zuber, R Karunamuni, JK Parsons, ...
bmj 360, 2018
Tranexamic acid in patients undergoing noncardiac surgery
PJ Devereaux, M Marcucci, TW Painter, D Conen, V Lomivorotov, ...
New England Journal of Medicine 386 (21), 1986-1997, 2022
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease
A Amin Al Olama, Z Kote-Jarai, FR Schumacher, F Wiklund, SI Berndt, ...
Human molecular genetics 22 (2), 408-415, 2013
Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis
B Malling, MA Røder, K Brasso, J Forman, M Taudorf, L Lönn
European radiology 29, 287-298, 2019
The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium
NM Davies, TR Gaunt, SJ Lewis, J Holly, JL Donovan, FC Hamdy, ...
Cancer Causes & Control 26, 1603-1616, 2015
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans
A Amin Al Olama, T Dadaev, DJ Hazelett, Q Li, D Leongamornlert, ...
Human molecular genetics 24 (19), 5589-5602, 2015
ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer
KD Berg, B Vainer, FB Thomsen, MA Røder, TA Gerds, BG Toft, K Brasso, ...
European urology 66 (5), 851-860, 2014
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
T Dadaev, EJ Saunders, PJ Newcombe, E Anokian, DA Leongamornlert, ...
Nature communications 9 (1), 2256, 2018
Does cytoreductive prostatectomy really have an impact on prognosis in prostate cancer patients with low-volume bone metastasis? Results from a prospective case-control study
T Steuber, KD Berg, MA Røder, K Brasso, P Iversen, H Huland, A Tiebel, ...
European urology focus 3 (6), 646-649, 2017
Trends in incidence and 5‐year mortality in men with newly diagnosed, metastatic prostate cancer—A population‐based analysis of 2 national cohorts
JT Helgstrand, MA Røder, N Klemann, BG Toft, DY Lichtensztajn, ...
Cancer 124 (14), 2931-2938, 2018
Short-term morbidity and mortality following radical cystectomy: a systematic review
SL Maibom, UN Joensen, AM Poulsen, H Kehlet, K Brasso, MA Røder
BMJ open 11 (4), e043266, 2021
Prediction of individual genetic risk to prostate cancer using a polygenic score
R Szulkin, T Whitington, M Eklund, M Aly, RA Eeles, D Easton, ...
The Prostate 75 (13), 1467-1474, 2015
Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate
FB Thomsen, MA Røder, P Rathenborg, K Brasso, M Borre, P Iversen
Scandinavian journal of urology 48 (3), 268-275, 2014
The system can't perform the operation now. Try again later.
Articles 1–20